ARCHIVES

Group Chairmen Propose Adding Four Trials For High Priority Status

This article is from The Cancer Letter archive.

Vol. 16 No. 27 | July 6, 1990

Download PDF Visit The Full Archive

Related Articles

Totality Of Evidence Causes Concern About New Findings.

December 7, 2007

House and Senate Appropriators Pledge to Increase Biomedical Research Funding.

March 5, 1999

In Brief: Survey Expected To Stimulate Surge Of Interest In Finding Etiological Factors In U .S. County-By-County Variations

April 19, 1974

RAS Mutations Can Predict Resistance To Vectibix, FOLFOX Combination Treatment

September 27, 2013

Low Dose Therapy Improves Survival Of Multiple Myeloma, ECOG Finds; Update At ASCO

May 25, 2007

ASCO President Swain: “Shattering Impact on Cancer Enterprise”

February 15, 2013